2 March 2017

PDMR Dealing

RNS Number : 3484Y

Verona Pharma PLC

02 March 2017

 

 

Verona Pharma plc

 

PDMR Dealing

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Dr. Jan-Anders Karlsson

2

Reason for the notification


a)


Position/status

 

 

Chief Executive Officer

b)

Initial notification/Amendment

 

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Verona Pharma plc

b)

LEI

 

n/a

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each

GB00BYW2KH80

b)

Nature of the transaction

 

 

Jan-Anders Karlsson purchased 19,750 Ordinary Shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

149 pence per Ordinary Share

12,000 Ordinary Shares

149 pence per Ordinary Share

7,750 Ordinary Shares

 

d)

Aggregated information

-         Aggregated volume

-         Price

 

 

19,750 Ordinary Shares at 149 pence per Ordinary Share

 

e)

Date of the transaction

12,000 Ordinary Shares on 28 February 2017 and 7,750 Ordinary Shares on 1 March 2017

f)

Place of the transaction

 

 

London Stock Exchange, AIM

 


This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

DSHEANDAEDFXEEF


For further information please contact:

 

Verona Pharma plc
Jan-Anders Karlsson, CEO
Victoria Stewart, Director of Communications
Tel: +44 (0)20 3283 4200
info@veronapharma.com

N+1 Singer (Nominated Adviser and UK Broker)
Aubrey Powell /Jen Boorer /Iqra Amin (Corporate Finance)
Brough Ransom /Mia Gardner (Corporate Broking)
Tel: +44 (0)20 3283 4200

 

 

Optimum Strategic Communications
(European Media and Investor enquiries)
Mary Clark, Annemarieke Ezendam
Hollie Vile
Tel: +44 (0) 203 922 0891
verona@optimumcomms.com

Westwicke, an ICR Company (Investor enquiries)
Stephanie Carrington
Tel. +1 646-277-1282
Stephanie.Carrington@icrinc.com


Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us